Denileukin diftitox Active Not Recruiting Phase 2 Trials for Melanoma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00515528Vaccination Plus Ontak in Patients With Metastatic Melanoma